Amnesteem Cannot Claim “Esteem,” FDA Tells Mylan In Letter On Acne Drug
Executive Summary
FDA is citing Mylan for claims on Amesteem's website that the acne product can address problems with low self-esteem
You may also be interested in...
Mylan Gets First-Ever GMP Warning Letter
FDA’s GMP warning letter to Mylan cites failure to complete a required content uniformity test for generic Imodium manufactured at Puerto Rico plant.
Websites Must Be Submitted To FDA Like Other Ads, Agency Reminds Industry
A recent theme of FDA advertising enforcement letters is a reminder to companies to submit promotional websites to the agency as they would any other marketing materials
Websites Must Be Submitted To FDA Like Other Ads, Agency Reminds Industry
A recent theme of FDA advertising enforcement letters is a reminder to companies to submit promotional websites to the agency as they would any other marketing materials